Abstract
Chronic pain management presents significant challenges, especially in the context of the ongoing opioid epidemic. Pain management practitioners are actively seeking safer and more effective alternatives to treat pain. Cannabis-based medicine, with its long history of use, is now being examined through a scientific, evidence-based approach. In particular, research is focusing on the potential medical benefits of cannabidiol (CBD), a non-psychoactive component of the cannabis plant. This article provides an assessment of the current evidence on the role of CBD in chronic pain management.
Introduction
As the opioid epidemic continues to impact communities, the need for alternative pain management approaches has become increasingly urgent. Traditionally, the psychoactive component of the cannabis plant, Δ9-tetrahydrocannabinol (THC), has received more attention. However, recent scientific studies have shed light on the potential therapeutic properties of CBD, another component of the cannabis plant. This article aims to explore the current evidence on the role of CBD in chronic pain management.
Current Evidence on CBD and Pain Management
To assess the potential role of CBD in pain management, we examined recent literature and focused on nabiximols, a pharmaceutical product that contains a 1:1 ratio of THC and CBD. While it is difficult to attribute the therapeutic properties solely to CBD due to the presence of THC in nabiximols, the available literature provides insights into the potential benefits of CBD in pain management.
It is important to note that there are currently no approved pharmaceutical products that contain CBD alone for pain management. However, CBD products are available as supplements, although their efficacy claims lack appropriate clinical studies. More research is needed to fully understand the potential of CBD in chronic pain management.
Conclusion
In conclusion, the role of CBD in chronic pain management is an area of ongoing investigation. While the available evidence suggests potential benefits, further research is needed to establish the efficacy of CBD as a standalone treatment for pain. Pain management practitioners should stay informed about the evolving landscape of CBD research and consider its potential as part of a comprehensive pain management strategy.
Keywords: cannabidiol, CBD, opioid, cannabis, tetrahydrocannabinol
Longtails: cannabidiol, CBD, opioid, cannabis, tetrahydrocannabinol
References
1. Best Pract Res Clin Anaesthesiol. 2020 Sep;34(3):463-477. doi: 10.1016/j.bpa.2020.06.004.
2. Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):17-35. doi: 10.1007/s00406-019-00978-2.
3. Postgrad Med. 2020 Jan;132(1):56-61. doi: 10.1080/00325481.2019.1685298.
4. J Neuroimmune Pharmacol. 2022 Jun;17(1-2):318-333. doi: 10.1007/s11481-021-10010-x.
5. Drugs R D. 2003;4(5):306-9. doi: 10.2165/00126839-200304050-00005.
